NCBI » Bookshelf » Health Services/Technology Assessment Text (HSTAT) » U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews » Use of Aspirin and NSAIDs to Prevent Colorectal Cancer
 
hsevidsyn
U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews
U.S. Preventive Services Task Force Evidence Syntheses
public health

Chapter  45:  Use of Aspirin and NSAIDs to Prevent Colorectal Cancer

A40623

Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850

www.ahrq.gov

Contract No. 290-02-0021

Prepared by:

University of Ottawa Evidence-based Practice Center at

The University of Ottawa, Ottawa Canada

David Moher, PhD

Director

Investigators

Alaa Rostom, MD, MSc, FRCPC

Catherine Dube, MD, MSc, FRCPC

Gabriela Lewin, MD

Alexander Tsertsvadze, MD Msc

Nicholas Barrowman, PhD

Catherine Code, MD, FRCPC

Margaret Sampson, MILS

David Moher, PhD

AHRQ Publication No. 07-0596-EF-1

March 2007

Suggested Citation: Rostom A, Dube C, Lewin G. Use of Aspirin and NSAIDs to Prevent Colorectal Cancer: An Evidence Synthesis. Prepared for the Agency for Healthcare Research and Quality by the University of Ottawa Evidence-based Practice Center at the University of Ottawa, Ottawa Canada, under Contract No. 290-02-0021. AHRQ Publication No. 07-0596-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality. March 2007.

This report is based on research conducted by the University of Ottawa Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0021). Funding was provided by the Centers for Disease Control and Prevention. The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.

This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders.

Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850

www.ahrq.gov

Contract No. 290-02-0021

Prepared by:

University of Ottawa Evidence-based Practice Center at

The University of Ottawa, Ottawa Canada

David Moher, PhD

Director

Investigators

Alaa Rostom, MD, MSc, FRCPC

Catherine Dube, MD, MSc, FRCPC

Gabriela Lewin, MD

Alexander Tsertsvadze, MD Msc

Nicholas Barrowman, PhD

Catherine Code, MD, FRCPC

Margaret Sampson, MILS

David Moher, PhD

AHRQ Publication No. 07-0596-EF-1

March 2007

Suggested Citation: Rostom A, Dube C, Lewin G. Use of Aspirin and NSAIDs to Prevent Colorectal Cancer: An Evidence Synthesis. Prepared for the Agency for Healthcare Research and Quality by the University of Ottawa Evidence-based Practice Center at the University of Ottawa, Ottawa Canada, under Contract No. 290-02-0021. AHRQ Publication No. 07-0596-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality. March 2007.

This report is based on research conducted by the University of Ottawa Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0021). Funding was provided by the Centers for Disease Control and Prevention. The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.

This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders.

Contents

Preface

Acknowledgments

Structured Abstract

Chapter 1. Introduction

Chapter 2. Methods

Chapter 3. Results

Chapter 4. Discussion

Appendix 1. Search strategies

Appendix 2. Study Selection—Screening Forms

Appendix 3. Quality Rating Criteria

Appendix 4. Detailed Report Supporting Sections

Appendix 5. Results: Harms Due to COX-2 Inhibitor Use (Including COX-2 Selective)

Appendix 6. Results: The Impact of NSAID Chemoprevention on FOBT Testing

Appendix 7. QUOROM flowchart

Appendix 8. Figures and Tables

References

References for Appendix 8

Help ǀ Contact Bookshelf
U.S. Preventive Services Task Force Evidence Syntheses
(navigation arrows) Go to previous chapter Go to next chapter Go to top of this page Go to bottom of this page Go to Table of Contents